Digital RESI Pitch Session

Interested in Connecting? Please contact:
David Mead
CEO and Co-Founder
dmead@varigenbio.com

Message the company or request a 1:1 meeting here

Varigen Biosciences is a synthetic biology-based drug discovery company focused on producing drug leads directly from the information encoded in microbial DNA. Varigen Biosciences has built a new generation of DNA manipulation tools that streamlines the translation of genomic information into microbial metabolites—natural product molecules—that have potential as new medicines.  Varigen can interrogate the metabolic output of microbes more efficiently than our competitors, so we are in a better position to be the first to discover therapeutically compelling microbial compounds.  We aim to be the leader in new therapeutics discovery from natural sources by expressing and modifying any metabolite encoded in the microbial microbiome.

Pitch Video

Varigen Biosciences Introduction